Countries citing scholars working at Tanabe Pharma Corporation (Japan)
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at Tanabe Pharma Corporation (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Tanabe Pharma Corporation (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanabe Pharma Corporation (Japan) more than expected).
Fields of papers published by authors at Tanabe Pharma Corporation (Japan)
This network shows the impact of papers affiliated with Tanabe Pharma Corporation (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Tanabe Pharma Corporation (Japan) at the time of their publication.
About Tanabe Pharma Corporation (Japan)
In recent decades, authors affiliated with Tanabe Pharma Corporation (Japan) have published 1.1k papers, which have received a total of 28.4k indexed citations . Scholars at this organization have produced 64 papers in Pharmacology, 99 papers in Endocrinology, Diabetes and Metabolism, 45 papers in Nephrology, 36 papers in Hepatology and 56 papers in Neurology on the topics of Diabetes Treatment and Management (86 papers), Pharmacogenetics and Drug Metabolism (47 papers), Amyotrophic Lateral Sclerosis Research (45 papers), Computational Drug Discovery Methods (37 papers), Carcinogens and Genotoxicity Assessment (37 papers), Synthesis and biological activity (31 papers), Analytical Methods in Pharmaceuticals (26 papers) and Rheumatoid Arthritis Research and Therapies (24 papers). Their work is cited by papers focused on Biological Psychiatry (371 citations), Hepatology (2.2k citations), Endocrinology, Diabetes and Metabolism (2.5k citations), Nephrology (1.2k citations) and Pharmacology (1.1k citations). Authors at Tanabe Pharma Corporation (Japan) collaborate with scholars in Japan, United States and United Kingdom and have published in prestigious journals including Scientific Reports, Bioorganic & Medicinal Chemistry Letters, PLoS ONE, Mutation Research/Genetic Toxicology and Environmental Mutagenesis and Chemical and Pharmaceutical Bulletin. Some of Tanabe Pharma Corporation (Japan)'s most productive authors include Takuma Tsuchida, Scott L. Friedman, Kenji Chiba, Yutaka Nakagawa, Takashi Kadowaki, Yoshiya Tanaka, Nobuya Inagaki, Toru Yoshinari, Noriko Sato and Yasushi Kajii.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact